Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) had Return on Investments of -15.19% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-1.87M |
|
-- |
|
-- |
|
$1.97M |
|
$-1.97M |
|
$0.10M |
|
$-1.87M |
|
$-1.87M |
|
$-1.87M |
|
$-1.87M |
|
$-1.87M |
|
$-1.87M |
|
$-1.97M |
|
$-1.97M |
|
6.38M |
|
6.38M |
|
$-0.48 |
|
$-0.48 |
|
| Balance Sheet Financials | |
$13.43M |
|
$0.18M |
|
$0.39M |
|
$13.81M |
|
$1.48M |
|
-- |
|
-- |
|
$1.48M |
|
$12.33M |
|
$12.33M |
|
$12.33M |
|
4.71M |
|
| Cash Flow Statement Financials | |
$-11.13M |
|
$5.39M |
|
$7.16M |
|
$6.15M |
|
$7.56M |
|
$1.42M |
|
$0.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-11.13M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.19% |
|
-15.19% |
|
-13.56% |
|
|
Return on Investments |
-15.19% |
$2.62 |
|
$-1.75 |
|
$-1.75 |
|